Thyrocare Technologies Balance Sheet Health
Financial Health criteria checks 5/6
Thyrocare Technologies has a total shareholder equity of ₹5.3B and total debt of ₹216.0M, which brings its debt-to-equity ratio to 4.1%. Its total assets and total liabilities are ₹6.4B and ₹1.2B respectively. Thyrocare Technologies's EBIT is ₹904.2M making its interest coverage ratio 21.5. It has cash and short-term investments of ₹1.8B.
Key information
4.1%
Debt to equity ratio
₹216.00m
Debt
Interest coverage ratio | 21.5x |
Cash | ₹1.80b |
Equity | ₹5.28b |
Total liabilities | ₹1.16b |
Total assets | ₹6.44b |
Recent financial health updates
Recent updates
A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)
Jun 12Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?
Oct 28Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares
Oct 07The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More
Sep 29Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?
Sep 11Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares
Aug 22Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings
Aug 17Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Jul 30Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking
Jul 28Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 04Financial Position Analysis
Short Term Liabilities: THYROCARE's short term assets (₹2.8B) exceed its short term liabilities (₹904.8M).
Long Term Liabilities: THYROCARE's short term assets (₹2.8B) exceed its long term liabilities (₹257.7M).
Debt to Equity History and Analysis
Debt Level: THYROCARE has more cash than its total debt.
Reducing Debt: THYROCARE's debt to equity ratio has increased from 0.6% to 4.1% over the past 5 years.
Debt Coverage: THYROCARE's debt is well covered by operating cash flow (776%).
Interest Coverage: THYROCARE's interest payments on its debt are well covered by EBIT (21.5x coverage).